chr12:102395874:> Detail (hg38)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr12:102,789,652-102,875,522 |
hg38 | chr12:102,395,874-102,481,744 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.004 | squamous cell carcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Carcinoma, Transitional Cell | NA | BeFree | Detail | |
0.001 | Cardiomyopathy, Dilated | NA | BeFree | Detail | |
0.003 | hypertrophic cardiomyopathy | NA | BeFree,LHGDN | Detail | |
0.011 | Cardiovascular Diseases | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | Carotid Artery Diseases | NA | LHGDN | Detail | |
<0.001 | CNS disorder | NA | BeFree | Detail | |
<0.001 | cerebral infarction | NA | BeFree | Detail | |
0.081 | brain ischemia | NA | BeFree,RGD | Detail | |
0.003 | cerebral palsy | NA | LHGDN | Detail | |
0.001 | Malignant tumor of cervix | The association between these polymorphisms, tissue and blood serum levels of IG... | BeFree | 25384883 | Detail |
0.003 | Primary biliary cirrhosis | NA | BeFree,GAD | Detail | |
0.200 | cholestasis | NA | BeFree,CTD_human,RGD | Detail | |
<0.001 | Congenital anomaly of cartilage | NA | BeFree | Detail | |
<0.001 | chondrosarcoma | NA | BeFree | Detail | |
0.002 | chorioamnionitis | NA | GAD | Detail | |
0.120 | colitis | NA | CTD_human | Detail | |
0.010 | Colonic Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | Colonic Polyps | NA | BeFree,GAD | Detail | |
0.008 | colorectal carcinoma | These data suggested that inhibiting cytohesins or ARNO as cytoplasmic activator... | BeFree | 24618737 | Detail |
0.008 | colorectal carcinoma | Given the role of insulin resistance in colorectal cancer (CRC), we explored whe... | BeFree | 25557790 | Detail |
0.008 | colorectal carcinoma | We elucidated the potential signaling pathway, IFN-γ/IRF1/miR-29b/IGF1, and its ... | BeFree | 25592039 | Detail |
0.016 | Colorectal Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Connective Tissue Diseases | NA | GAD | Detail | |
0.120 | Corneal Diseases | NA | CTD_human | Detail | |
0.001 | Coronary Arteriosclerosis | NA | BeFree | Detail | |
0.004 | Coronary heart disease | NA | BeFree,LHGDN | Detail | |
0.121 | Crohn Disease | NA | BeFree,CTD_human | Detail | |
<0.001 | Delirium | NA | BeFree | Detail | |
<0.001 | Presenile dementia | These results suggest that IGF-I increases in response to neuropathological chan... | BeFree | 24820016 | Detail |
0.080 | Dementia, Vascular | NA | BeFree,RGD | Detail | |
0.120 | Demyelinating Diseases | NA | CTD_human | Detail | |
0.001 | Mental Depression | In our study, elevated IGF-I levels were significantly associated with depressio... | BeFree | 25836355 | Detail |
0.001 | depressive disorder | In our study, elevated IGF-I levels were significantly associated with depressio... | BeFree | 25836355 | Detail |
0.009 | Diabetes | These findings suggest that IGF-1 is an important paracrine factor that mediates... | BeFree | 25287599 | Detail |
0.013 | diabetes mellitus | These findings suggest that IGF-1 is an important paracrine factor that mediates... | BeFree,GAD | 25287599 | Detail |
0.200 | Diabetes Mellitus, Experimental | NA | CTD_human,RGD | Detail | |
0.125 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree,CTD_human,GAD | Detail | |
0.109 | Diabetes Mellitus, Non-Insulin-Dependent | The Uyghur population and genetic susceptibility to type 2 diabetes: potential r... | BeFree,GAD,LHGDN,RGD | 25785549 | Detail |
0.003 | Diabetic Angiopathies | NA | LHGDN | Detail | |
0.003 | Diabetic Nephropathy | NA | BeFree,LHGDN | Detail | |
0.080 | Diabetic Neuropathies | NA | RGD | Detail | |
0.012 | diabetic retinopathy | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Drug abuse | NA | BeFree | Detail | |
0.020 | Dwarfism | The GH and IGF-1 characteristics of children with short stature were not differe... | BeFree,GAD | 25659810 | Detail |
0.020 | Dwarfism | Given the relative common occurrence of defects of the GH/IGF-I axis in children... | BeFree,GAD | 25664603 | Detail |
0.020 | Dwarfism | The current study evaluates the relative contribution of these two factors contr... | BeFree,GAD | 25835289 | Detail |
0.002 | Pituitary dwarfism | Patients with severe IGHD had a higher frequency of consanguinity, were shorter,... | BeFree | 25116472 | Detail |
<0.001 | Emaciation | NA | BeFree | Detail | |
<0.001 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
0.003 | Endometrial Neoplasms | NA | LHGDN | Detail | |
0.124 | endometriosis | NA | BeFree,CTD_human,LHGDN | Detail | |
<0.001 | Enterocolitis | NA | BeFree | Detail | |
0.008 | Esophageal Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | esophagitis | NA | GAD | Detail | |
<0.001 | peptic esophagitis | NA | BeFree | Detail | |
<0.001 | External exotoses | NA | BeFree | Detail | |
0.006 | Failure to Thrive | The results of the in-vitro study do not support the hypothesis that IGF-I/IGF-I... | BeFree | 25066218 | Detail |
0.006 | Failure to Thrive | By contrast, IGF1 insensitivity results in pre- and postnatal growth failure ass... | BeFree | 25411237 | Detail |
0.002 | Fetal Diseases | NA | GAD | Detail | |
0.090 | Fetal Growth Retardation | NA | GAD,LHGDN,RGD | Detail | |
0.002 | Fetal Membranes, Premature Rupture | NA | GAD | Detail | |
<0.001 | breast fibrocystic disease | NA | BeFree | Detail | |
0.003 | Fibrosis | NA | LHGDN | Detail | |
<0.001 | pathologic fistula | NA | BeFree | Detail | |
0.003 | Folic Acid Deficiency | NA | LHGDN | Detail | |
<0.001 | fragile X syndrome | Examples of the latter include mGluR5 antagonists in FXS, mTOR inhibitors in TSC... | BeFree | 25695134 | Detail |
<0.001 | gastrinoma | NA | BeFree | Detail | |
<0.001 | Giant Cell Tumors | NA | BeFree | Detail | |
<0.001 | glaucoma | In an effort to determine whether hNPs could be used a candidate cells for targe... | BeFree | 25923430 | Detail |
0.006 | glioblastoma | NA | BeFree,LHGDN | Detail | |
0.007 | Glioma | NA | BeFree,LHGDN | Detail | |
<0.001 | glomerulonephritis | NA | BeFree | Detail | |
<0.001 | IgA glomerulonephritis | NA | BeFree | Detail | |
<0.001 | Nodular glomerulosclerosis | NA | BeFree | Detail | |
<0.001 | nodular goiter | NA | BeFree | Detail | |
<0.001 | Graves Disease | NA | BeFree | Detail | |
0.005 | Growth Disorders | NA | GAD,LHGDN | Detail | |
0.003 | Head and Neck Neoplasms | NA | LHGDN | Detail | |
0.001 | Sensorineural Hearing Loss (disorder) | NA | BeFree | Detail | |
0.003 | Heart Diseases | NA | BeFree,LHGDN | Detail | |
0.120 | Cardiomegaly | NA | CTD_human | Detail | |
0.083 | Heart failure | NA | BeFree,RGD | Detail | |
0.003 | congestive heart failure | NA | BeFree | Detail | |
<0.001 | Ventricular Septal Defects | NA | BeFree | Detail | |
<0.001 | hepatitis B | NA | BeFree | Detail | |
<0.001 | hepatitis C | To evaluate the expression of different insulin-like growth factor (IGF)-1 mRNA ... | BeFree | 25852271 | Detail |
0.120 | Diaphragmatic hernia | NA | CTD_human | Detail | |
<0.001 | HIV Infections | NA | BeFree | Detail | |
<0.001 | Hodgkin Disease | NA | BeFree | Detail | |
0.001 | Huntington disease | Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner... | BeFree | 24992836 | Detail |
<0.001 | Hydatidiform mole | NA | BeFree | Detail | |
0.120 | Hyperalgesia | NA | CTD_human | Detail | |
0.002 | hyperglycemia | NA | BeFree | Detail | |
0.002 | hyperinsulinism | NA | BeFree | Detail | |
0.080 | Hyperphagia | NA | RGD | Detail | |
0.005 | Hyperplasia | NA | GAD,LHGDN | Detail | |
<0.001 | hyperprolactinemia | NA | BeFree | Detail | |
0.213 | Hypertensive disease | NA | BeFree,CTD_human,GAD,LHGDN,RGD | Detail | |
0.003 | hyperthyroidism | NA | LHGDN | Detail | |
0.003 | hypoglycemia | NA | BeFree | Detail | |
<0.001 | hypogonadism | NA | BeFree | Detail | |
<0.001 | hypopituitarism | NA | BeFree | Detail | |
0.001 | hypothyroidism | NA | BeFree | Detail | |
<0.001 | ileitis | NA | BeFree | Detail | |
0.007 | Inflammation | NA | GAD,LHGDN | Detail | |
0.003 | Inflammatory Bowel Diseases | NA | LHGDN | Detail | |
0.005 | Insulin resistance | NA | GAD | Detail | |
0.080 | Intervertebral Disk Displacement | NA | RGD | Detail | |
0.002 | ischemia | Using a mouse model of ischemia-reperfusion, we demonstrate that intravenous del... | BeFree | 24604065 | Detail |
0.002 | ischemia | In our study, BMSCs were modified with insulin-like growth factor-1 (IGF-1) gene... | BeFree | 25767192 | Detail |
<0.001 | Keloid | NA | BeFree | Detail | |
0.126 | Kidney Diseases | NA | BeFree,CTD_human,LHGDN | Detail | |
0.001 | Kidney Failure, Acute | NA | BeFree | Detail | |
0.121 | Kidney Failure, Chronic | NA | BeFree,CTD_human | Detail | |
<0.001 | kwashiorkor | NA | BeFree | Detail | |
0.002 | Premature Obstetric Labor | NA | GAD | Detail | |
0.014 | Fibroid Tumor | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | leiomyosarcoma | NA | BeFree | Detail | |
<0.001 | leukemia | A subset of bone marrow stromal cells regulate ATP-binding cassette gene express... | BeFree | 25095896 | Detail |
<0.001 | chronic lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Leukemia, Lymphocytic, Acute, L1 | NA | BeFree | Detail | |
0.003 | Leukemia, Myelocytic, Acute | NA | BeFree,LHGDN | Detail | |
0.003 | myeloid leukemia | Here, the involvement of IGF-I in inducing multidrug resistance in a myeloid leu... | BeFree,LHGDN | 25095896 | Detail |
<0.001 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
<0.001 | acute myelomonocytic leukemia | NA | BeFree | Detail | |
<0.001 | Leydig cell tumor | NA | BeFree | Detail | |
0.010 | liver cirrhosis | NA | BeFree,LHGDN | Detail | |
<0.001 | Biliary cirrhosis | NA | BeFree | Detail | |
0.200 | Liver Cirrhosis, Experimental | NA | CTD_human,RGD | Detail | |
0.006 | Liver diseases | NA | BeFree,GAD,LHGDN | Detail | |
0.005 | Liver neoplasms | NA | BeFree,GAD | Detail | |
0.002 | Low Birth Weights | NA | GAD | Detail | |
0.002 | Chronic Obstructive Airway Disease | NA | GAD | Detail | |
0.003 | Lung Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | lymphoma | NA | BeFree | Detail | |
0.002 | Lymphoma, Non-Hodgkin | NA | GAD | Detail | |
<0.001 | Waldenstrom Macroglobulinemia | NA | BeFree | Detail | |
<0.001 | macular degeneration | NA | BeFree | Detail | |
<0.001 | malaria | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of stomach | Together, IGF-1/Akt/FoxO1 regulatory machinery appears to be a previously unappr... | BeFree | 25596089 | Detail |
0.080 | Malocclusion | NA | RGD | Detail | |
0.002 | Animal Mammary Neoplasms | NA | GAD | Detail | |
0.120 | Mammary Neoplasms, Experimental | NA | CTD_human | Detail | |
<0.001 | medulloblastoma | NA | BeFree | Detail | |
0.009 | melanoma | NA | BeFree,LHGDN | Detail | |
0.003 | meningioma | NA | BeFree,LHGDN | Detail | |
<0.001 | Mental Retardation | NA | BeFree | Detail | |
0.001 | Metabolic Diseases | Excessive secretion of the growth hormone (GH) leads to hepatic secretion of ins... | BeFree | 25923102 | Detail |
0.002 | Metaplasia | NA | GAD | Detail | |
<0.001 | Microangiopathy, Diabetic | NA | BeFree | Detail | |
<0.001 | microcephaly | To identify and characterize IGF1R gene variations in a cohort of 28 Argentinean... | BeFree | 25040157 | Detail |
<0.001 | Micrognathism | NA | BeFree | Detail | |
0.013 | multiple myeloma | RGZ was able to concentration‑dependently inhibit the expression of HIF1α and IG... | BeFree,GAD,LHGDN | 25050627 | Detail |
0.013 | multiple myeloma | Furthermore, exposure of AZD8055-treated cells to IGF1 induced p-Akt S(473) and ... | BeFree,GAD,LHGDN | 25172964 | Detail |
<0.001 | multiple sclerosis | NA | BeFree | Detail | |
0.123 | muscular atrophy | Spinal muscular atrophy mice administered AAV1-IGF-1 on postnatal day 1 exhibite... | BeFree,CTD_human | 24814151 | Detail |
0.001 | spinal muscular atrophy | These data indicate that systemically delivered AAV1-IGF-1 can correct several o... | BeFree | 24814151 | Detail |
0.001 | spinal muscular atrophy | Recent evidence of IGF-1 axis alteration in spinal muscular atrophy (SMA), a ver... | BeFree | 26311784 | Detail |
0.002 | muscular dystrophy | NA | BeFree | Detail | |
0.002 | Musculoskeletal Diseases | NA | GAD | Detail | |
0.099 | myocardial infarction | Using a mouse model of ischemia-reperfusion, we demonstrate that intravenous del... | BeFree,GAD,LHGDN,RGD | 24604065 | Detail |
0.099 | myocardial infarction | Localized delivery of mechano-growth factor E-domain peptide via polymeric micro... | BeFree,GAD,LHGDN,RGD | 25678113 | Detail |
0.004 | myopia | NA | BeFree,GAD | Detail | |
<0.001 | myositis | NA | BeFree | Detail | |
0.120 | Neoplasm Invasiveness | NA | CTD_human | Detail | |
0.125 | Neoplasm Metastasis | IFN-γ-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell grow... | BeFree,CTD_human | 25592039 | Detail |
0.125 | Neoplasm Metastasis | Although many of the relevant molecular pathways and intracellular cascades rema... | BeFree,CTD_human | 25743390 | Detail |
0.120 | Nerve Degeneration | NA | CTD_human | Detail | |
<0.001 | neurilemmoma | NA | BeFree | Detail | |
0.004 | neuroblastoma | NA | BeFree | Detail | |
<0.001 | Neuromuscular Diseases | NA | BeFree | Detail | |
<0.001 | Noonan syndrome | NA | BeFree | Detail | |
0.012 | obesity | An increased expression of LEP and IGF1 was detected in the subcutaneous fat of ... | BeFree,GAD | 24690978 | Detail |
0.012 | obesity | Relationship between serum IGF-1 and skeletal muscle IGF-1 mRNA expression to ph... | BeFree,GAD | 25375982 | Detail |
0.091 | Degenerative polyarthritis | NA | BeFree,GAD,RGD | Detail | |
0.003 | Osteochondrodysplasias | NA | LHGDN | Detail | |
0.089 | osteoporosis | NA | BeFree,GAD,LHGDN,RGD | Detail | |
0.006 | osteosarcoma | NA | BeFree,LHGDN | Detail | |
0.002 | ovarian carcinoma | NA | BeFree | Detail | |
0.001 | Ovarian Diseases | NA | BeFree | Detail | |
<0.001 | Pain | Three specific genes in the pain group overlap with sleep quality, including ins... | BeFree | 25358868 | Detail |
0.010 | Pancreatic Neoplasm | NA | GAD,LHGDN | Detail | |
<0.001 | papilloma | NA | BeFree | Detail | |
<0.001 | Paresis | NA | BeFree | Detail | |
0.120 | Peripheral neuropathy | NA | CTD_human | Detail | |
<0.001 | pheochromocytoma | NA | BeFree | Detail | |
0.002 | pituitary adenoma | NA | BeFree | Detail | |
0.008 | Pituitary Diseases | Furthermore, precocious ethynylestradiol (EE) exposure induced lasting effects o... | BeFree | 25058367 | Detail |
0.008 | Pituitary Diseases | Analysis of the GH/IGF1 pathway was done evaluating the expression of several hy... | BeFree | 26134413 | Detail |
0.121 | Pituitary Neoplasms | NA | BeFree,CTD_human | Detail | |
0.003 | Placenta Disorders | NA | LHGDN | Detail | |
<0.001 | plasmacytoma | NA | BeFree | Detail | |
0.003 | Pleural effusion disorder | NA | LHGDN | Detail | |
<0.001 | pneumonia | NA | BeFree | Detail | |
0.011 | polycystic ovary syndrome | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | polycythemia vera | NA | BeFree | Detail | |
<0.001 | polyps | Regarding the IGFBP3 polymorphism, the absence of an A allele at the -202 positi... | BeFree | 25385818 | Detail |
<0.001 | Prader-Willi syndrome | NA | BeFree | Detail | |
0.007 | pre-eclampsia | NA | GAD,LHGDN | Detail | |
<0.001 | Precancerous Conditions | NA | BeFree | Detail | |
<0.001 | Pregnancy Complications | NA | BeFree | Detail | |
0.002 | Pregnancy Complications, Hematologic | NA | GAD | Detail | |
<0.001 | Premenstrual syndrome | Examples of the latter include mGluR5 antagonists in FXS, mTOR inhibitors in TSC... | BeFree | 25695134 | Detail |
<0.001 | Prostatic Diseases | NA | BeFree | Detail | |
0.222 | Prostatic Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN,RGD | Detail | |
0.001 | psoriasis | NA | BeFree | Detail | |
0.002 | Delayed puberty | NA | GAD | Detail | |
0.122 | Precocious Puberty | NA | CTD_human,GAD | Detail | |
0.124 | pulmonary fibrosis | NA | BeFree,CTD_human,LHGDN | Detail | |
<0.001 | Rabies (disorder) | NA | BeFree | Detail | |
<0.001 | kidney failure | NA | BeFree | Detail | |
<0.001 | Respiratory Distress Syndrome, Adult | NA | BeFree | Detail | |
0.001 | Retinal Diseases | NA | BeFree | Detail | |
<0.001 | retinoblastoma | NA | BeFree | Detail | |
0.084 | retinopathy of prematurity | NA | BeFree,GAD,RGD | Detail | |
<0.001 | Retroviridae Infections | NA | BeFree | Detail | |
<0.001 | Rett syndrome | NA | BeFree | Detail | |
0.001 | rhabdomyosarcoma | NA | BeFree | Detail | |
0.001 | sarcoidosis | NA | BeFree | Detail | |
<0.001 | Kaposi sarcoma | NA | BeFree | Detail | |
<0.001 | schizophrenia | NA | BeFree | Detail | |
0.003 | systemic scleroderma | NA | BeFree,LHGDN | Detail | |
0.005 | Scoliosis, unspecified | NA | GAD | Detail | |
<0.001 | Shy-Drager Syndrome | NA | BeFree | Detail | |
0.002 | Dermatologic disorders | NA | GAD | Detail | |
<0.001 | ankylosing spondylitis | IGF-1 and ADMA levels are inversely correlated in nondiabetic ankylosing spondyl... | BeFree | 25295265 | Detail |
0.090 | Cerebrovascular accident | NA | BeFree,GAD,LHGDN,RGD | Detail | |
0.003 | Subarachnoid Hemorrhage | NA | BeFree,GAD | Detail | |
<0.001 | synovial sarcoma | NA | BeFree | Detail | |
<0.001 | telangiectasis | NA | BeFree | Detail | |
0.005 | Testicular Neoplasms | NA | GAD | Detail | |
<0.001 | tetanus | NA | BeFree | Detail | |
<0.001 | thalassemia | NA | BeFree | Detail | |
<0.001 | thromboangiitis obliterans | NA | BeFree | Detail | |
0.002 | Thyroid Diseases | NA | GAD | Detail | |
0.003 | Thyroid Neoplasm | NA | BeFree,LHGDN | Detail | |
<0.001 | Thyroid Nodule | NA | BeFree | Detail | |
0.005 | Tobacco use disorder | NA | GAD | Detail | |
<0.001 | Trisomy | NA | BeFree | Detail | |
<0.001 | tuberous sclerosis | NA | BeFree | Detail | |
0.002 | Turner syndrome | NA | BeFree | Detail | |
<0.001 | Unipolar Depression | IGF-I in major depression and antidepressant treatment response. | BeFree | 25836355 | Detail |
0.120 | Adverse reaction to drug | NA | CTD_human | Detail | |
<0.001 | ureteral obstruction | NA | BeFree | Detail | |
0.004 | Uterine Fibroids | NA | BeFree | Detail | |
0.002 | Uterine Neoplasms | NA | GAD | Detail | |
0.003 | Vascular Diseases | NA | BeFree,LHGDN | Detail | |
0.002 | Weight Gain | NA | GAD | Detail | |
<0.001 | Zollinger-Ellison syndrome | NA | BeFree | Detail | |
<0.001 | Ichthyosis, X-Linked | NA | BeFree | Detail | |
<0.001 | B-Cell Lymphomas | The absence of Esr2 resulted in increased apoptosis, decreased B-cell lymphoma 2... | BeFree | 25885794 | Detail |
0.004 | motor neuron disease | Recent evidence of IGF-1 axis alteration in spinal muscular atrophy (SMA), a ver... | BeFree,LHGDN | 26311784 | Detail |
<0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
<0.001 | gestational diabetes | GO terms relevant to translation and metabolic process and their related genes C... | BeFree | 25736406 | Detail |
0.002 | Ovarian Failure, Premature | NA | GAD | Detail | |
0.003 | antiphospholipid syndrome | NA | LHGDN | Detail | |
0.003 | Polycystic Kidney, Autosomal Dominant | NA | BeFree,LHGDN | Detail | |
<0.001 | essential hypertension | NA | BeFree | Detail | |
<0.001 | Liver failure | NA | BeFree | Detail | |
<0.001 | Synovial Cyst | Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retin... | BeFree | 25923430 | Detail |
0.080 | alcoholic neuropathy | NA | RGD | Detail | |
<0.001 | Ataxia, Spinocerebellar | NA | BeFree | Detail | |
<0.001 | Epstein-Barr Virus Infections | NA | BeFree | Detail | |
<0.001 | Left Ventricular Hypertrophy | NA | BeFree | Detail | |
<0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | obstructive nephropathy | NA | BeFree | Detail | |
<0.001 | Thyroid Gland Follicular Adenoma | NA | BeFree | Detail | |
<0.001 | Atrophic condition of skin | NA | BeFree | Detail | |
0.007 | Premature Birth | NA | GAD | Detail | |
0.204 | Myocardial Ischemia | NA | BeFree,CTD_human,LHGDN,RGD | Detail | |
<0.001 | Cutaneous Melanoma | NA | BeFree | Detail | |
<0.001 | Muscle Weakness | NA | BeFree | Detail | |
<0.001 | Coronary Occlusion | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of lung (disorder) | Our results suggest that TM4SF4 overexpression in lung carcinoma cells results i... | BeFree | 25344917 | Detail |
0.001 | esophageal carcinoma | Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclona... | BeFree | 25358597 | Detail |
<0.001 | Bone Cysts, Aneurysmal | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of mouth | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of bone | NA | BeFree | Detail | |
<0.001 | Benign neoplasm of uterus | NA | BeFree | Detail | |
0.005 | Malnutrition | NA | BeFree,LHGDN | Detail | |
<0.001 | Cicatrix, Hypertrophic | NA | BeFree | Detail | |
0.001 | Russell-Silver syndrome | IGF-I sensitivity in Silver-Russell syndrome with IGF2/H19 hypomethylation. | BeFree | 25066218 | Detail |
0.002 | Tumor Progression | NA | BeFree | Detail | |
<0.001 | follicular adenoma | NA | BeFree | Detail | |
<0.001 | Diabetes, Autoimmune | NA | BeFree | Detail | |
<0.001 | Lung Diseases, Interstitial | NA | BeFree | Detail | |
0.003 | hyperandrogenism | NA | BeFree,LHGDN | Detail | |
<0.001 | Neuroectodermal Tumors | NA | BeFree | Detail | |
<0.001 | Ki-1+ Anaplastic Large Cell Lymphoma | NA | BeFree | Detail | |
<0.001 | angiomyolipoma | NA | BeFree | Detail | |
<0.001 | embryonal carcinoma | NA | BeFree | Detail | |
<0.001 | Neuroectodermal Tumor, Primitive | NA | BeFree | Detail | |
<0.001 | Carcinoma, Large Cell | NA | BeFree | Detail | |
<0.001 | olfactory neuroblastoma | NA | BeFree | Detail | |
<0.001 | Neuroendocrine Tumors | NA | BeFree | Detail | |
<0.001 | uveal melanoma | NA | BeFree | Detail | |
<0.001 | Lip and oral cavity carcinoma | NA | BeFree | Detail | |
<0.001 | Metastatic malignant neoplasm to brain | NA | BeFree | Detail | |
<0.001 | Hyperparathyroidism, Primary | NA | BeFree | Detail | |
<0.001 | Premature aging syndrome | NA | BeFree | Detail | |
<0.001 | Extrapyramidal sign | NA | BeFree | Detail | |
<0.001 | Sore to touch | NA | BeFree | Detail | |
0.003 | pancreatic carcinoma | NA | BeFree | Detail | |
0.005 | Small for gestational age (disorder) | NA | GAD | Detail | |
<0.001 | Carcinoma of male breast | NA | BeFree | Detail | |
0.001 | Gastrointestinal Stromal Tumors | NA | BeFree | Detail | |
<0.001 | pycnodysostosis | NA | BeFree | Detail | |
<0.001 | Papillary thyroid carcinoma | An uncontrolled hyperactive GH-IGF-1 axis may play a dominant role in the develo... | BeFree | 25329702 | Detail |
<0.001 | Fibrosis, Liver | NA | BeFree | Detail | |
0.080 | coronary stenosis | NA | RGD | Detail | |
<0.001 | panhypopituitarism | NA | BeFree | Detail | |
<0.001 | Erectile dysfunction | NA | BeFree | Detail | |
0.009 | Malignant neoplasm of lung | NA | BeFree,GAD | Detail | |
<0.001 | age related macular degeneration | NA | BeFree | Detail | |
0.003 | Disease Progression | NA | LHGDN | Detail | |
<0.001 | Malignant neoplasm of male breast | NA | BeFree | Detail | |
<0.001 | fibrous dysplasia | NA | BeFree | Detail | |
<0.001 | Multiple tumors | NA | BeFree | Detail | |
<0.001 | Epithelial hyperplasia of skin | NA | BeFree | Detail | |
0.001 | Donohue syndrome | NA | BeFree | Detail | |
<0.001 | polymicrogyria | NA | BeFree | Detail | |
<0.001 | Niemann-Pick disease, type B | NA | BeFree | Detail | |
<0.001 | Endometrioma | NA | BeFree | Detail | |
<0.001 | Exudative age-related macular degeneration | NA | BeFree | Detail | |
0.001 | Severe myopia | NA | BeFree | Detail | |
<0.001 | Overproduction of growth hormone | NA | BeFree | Detail | |
0.003 | Somatotropin deficiency | Endocrine evaluation revealed low IGF-1 levels and borderline growth hormone def... | BeFree | 24458596 | Detail |
0.014 | Laron syndrome | NA | BeFree,GAD | Detail | |
0.002 | Impaired glucose tolerance | NA | BeFree | Detail | |
<0.001 | Rabson-Mendenhall syndrome | NA | BeFree | Detail | |
<0.001 | Central hypothyroidism | NA | BeFree | Detail | |
<0.001 | Carcinoma breast stage IV | NA | BeFree | Detail | |
<0.001 | Growth Hormone-Producing Pituitary Gland Neoplasm | In somatotropinomas, sst5TMD4 mRNA and protein levels correlated positively, and... | BeFree | 25637790 | Detail |
<0.001 | Metastatic melanoma | NA | BeFree | Detail | |
<0.001 | Cancer of Head and Neck | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of esophagus | NA | BeFree | Detail | |
0.001 | Adenocarcinoma Of Esophagus | NA | BeFree | Detail | |
<0.001 | cervical squamous cell carcinoma | Analysis of cytosine-adenine repeats in P1 promoter region of IGF-1 gene in peri... | BeFree | 25384883 | Detail |
<0.001 | Transitional cell carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | extraosseous Ewings sarcoma-primitive neuroepithelial tumor | NA | BeFree | Detail | |
0.001 | Solid tumour | NA | BeFree | Detail | |
<0.001 | stage, prostate cancer | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
<0.001 | Myomatous neoplasm | NA | BeFree | Detail | |
0.081 | Prostatic Intraepithelial Neoplasias | NA | BeFree,RGD | Detail | |
0.001 | cervix carcinoma | The association between these polymorphisms, tissue and blood serum levels of IG... | BeFree | 25384883 | Detail |
<0.001 | Menstrual spotting | NA | BeFree | Detail | |
<0.001 | Tumor necrosis | NA | BeFree | Detail | |
<0.001 | Multiple polyps | NA | BeFree | Detail | |
<0.001 | Carcinoid tumor no ICD-O subtype | NA | BeFree | Detail | |
<0.001 | Leydig cell tumor, benign | NA | BeFree | Detail | |
<0.001 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of colon | NA | BeFree | Detail | |
0.002 | Impaired cognition | NA | BeFree | Detail | |
<0.001 | Stable angina | NA | BeFree | Detail | |
<0.001 | Chronic liver disease | NA | BeFree | Detail | |
0.003 | Complications of Diabetes Mellitus | NA | LHGDN | Detail | |
<0.001 | Deficiency of testosterone biosynthesis | NA | BeFree | Detail | |
<0.001 | Large cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | malignant mesothelioma | NA | BeFree | Detail | |
<0.001 | Breast Cancer, Familial | NA | BeFree | Detail | |
<0.001 | Growth Hormone-Secreting Pituitary Adenoma | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of central nervous system | NA | BeFree | Detail | |
<0.001 | Ischemic cardiomyopathy | NA | BeFree | Detail | |
0.051 | Malignant neoplasm of prostate | Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic... | BeFree,GAD | 24904019 | Detail |
0.051 | Malignant neoplasm of prostate | A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inh... | BeFree,GAD | 25344862 | Detail |
0.080 | Endotoxemia | NA | RGD | Detail | |
<0.001 | multiple system atrophy | NA | BeFree | Detail | |
0.002 | thrombophilia | NA | GAD | Detail | |
<0.001 | Class III malocclusion | Analysis of the association of COL2A1 and IGF-1 with mandibular prognathism in a... | BeFree | 24386886 | Detail |
<0.001 | Non-alcoholic Fatty Liver Disease | NA | BeFree | Detail | |
<0.001 | Chronic Kidney Insufficiency | NA | BeFree | Detail | |
<0.001 | Testicular dysfunction | NA | BeFree | Detail | |
<0.001 | Idiopathic osteoarthritis | NA | BeFree | Detail | |
<0.001 | Muscle damage | NA | BeFree | Detail | |
<0.001 | Hypochondroplasia (disorder) | NA | BeFree | Detail | |
<0.001 | Osteodysplasia | NA | BeFree | Detail | |
0.001 | Adolescent idiopathic scoliosis | NA | BeFree | Detail | |
<0.001 | Developmental delay (disorder) | NA | BeFree | Detail | |
<0.001 | Dysmorphic features | NA | BeFree | Detail | |
<0.001 | Plasma cell tumor, malignant | NA | BeFree | Detail | |
0.004 | endometrial carcinoma | Metformin down-regulates endometrial carcinoma cell secretion of IGF-1 and expre... | BeFree | 25640355 | Detail |
0.004 | dementia | These results suggest that IGF-I increases in response to neuropathological chan... | BeFree,LHGDN | 24820016 | Detail |
<0.001 | Overweight | NA | BeFree | Detail | |
0.005 | body mass | NA | GAD | Detail | |
0.005 | Sleep Apnea, Obstructive | NA | LHGDN | Detail | |
0.003 | Metabolic syndrome X | NA | BeFree,LHGDN | Detail | |
0.004 | Neurodegenerative Disorders | As loss of protein homeostasis is a feature of many sporadic and inherited forms... | BeFree,LHGDN | 25102325 | Detail |
0.004 | Neurodegenerative Disorders | This aspect should be considered when designing IGF-1-based treatments for neuro... | BeFree,LHGDN | 26311784 | Detail |
0.003 | Hepatitis C, Chronic | NA | BeFree,LHGDN | Detail | |
0.003 | Malignant neoplasm of esophagus | NA | BeFree,GAD | Detail | |
0.002 | Thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Ewings sarcoma | By chromatin immunoprecipitation, we analyzed EWS-FLI1 binding to the promoters ... | BeFree | 25609059 | Detail |
<0.001 | Malignant glioma | NA | BeFree | Detail | |
<0.001 | Loss of scalp hair | NA | BeFree | Detail | |
0.004 | Osteosarcoma of bone | NA | BeFree | Detail | |
<0.001 | Carcinoma of larynx | NA | BeFree | Detail | |
0.012 | Carcinogenesis | To better understand the role GH/IGF-I plays in tumor formation, this study used... | BeFree | 25085903 | Detail |
0.012 | Carcinogenesis | Together, IGF-1/Akt/FoxO1 regulatory machinery appears to be a previously unappr... | BeFree | 25596089 | Detail |
<0.001 | Tumor Initiation | NA | BeFree | Detail | |
0.019 | prostate carcinoma | Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic... | BeFree | 24904019 | Detail |
0.019 | prostate carcinoma | A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inh... | BeFree | 25344862 | Detail |
<0.001 | Gastro-esophageal reflux disease with esophagitis | NA | BeFree | Detail | |
0.003 | Epithelial ovarian cancer | NA | BeFree,GAD | Detail | |
<0.001 | Progressive Neoplastic Disease | NA | BeFree | Detail | |
0.044 | breast carcinoma | Growth hormone (GH) and/or insulin-like growth factor I (IGF-I) are thought to p... | BeFree | 25085903 | Detail |
0.044 | breast carcinoma | IGF-1 is a point of convergence for major signaling pathways implicated in breas... | BeFree | 25743390 | Detail |
0.044 | breast carcinoma | Induction of anterior gradient 2 (AGR2) plays a key role in insulin-like growth ... | BeFree | 25956506 | Detail |
<0.001 | polycythemia vera | JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation... | BeFree | 16239216 | Detail |
0.004 | Carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Ewings sarcoma-primitive neuroectodermal tumor (PNET) | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
0.005 | colon carcinoma | NA | BeFree | Detail | |
0.003 | stomach carcinoma | Together, IGF-1/Akt/FoxO1 regulatory machinery appears to be a previously unappr... | BeFree | 25596089 | Detail |
<0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | skin carcinoma | NA | BeFree | Detail | |
0.004 | Central neuroblastoma | NA | BeFree | Detail | |
<0.001 | acne | The significant association between strong IGF-1, high BMI, and severe acne unde... | BeFree | 25803999 | Detail |
0.005 | Microalbuminuria | NA | BeFree,GAD | Detail | |
<0.001 | Middle Cerebral Artery Occlusion | NA | BeFree | Detail | |
0.001 | Premenopausal breast cancer | NA | BeFree | Detail | |
<0.001 | Cerebellar lesion NOS | NA | BeFree | Detail | |
<0.001 | growth hormone treatment | NA | BeFree | Detail | |
<0.001 | End Stage Liver Disease | NA | BeFree | Detail | |
<0.001 | early pregnancy | NA | BeFree | Detail | |
<0.001 | lymphangioleiomyomatosis | NA | BeFree | Detail | |
0.080 | Hypoxia-Ischemia, Brain | NA | RGD | Detail | |
<0.001 | Lewy Body Disease | NA | BeFree | Detail | |
<0.001 | Atrophy, Muscular, Spinobulbar | NA | BeFree | Detail | |
<0.001 | SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1 | NA | BeFree | Detail | |
<0.001 | malignant pleural mesothelioma | NA | BeFree | Detail | |
<0.001 | Oestrogen deficiency | NA | BeFree | Detail | |
<0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
<0.001 | Catabolic state | NA | BeFree | Detail | |
0.120 | Diabetic Cardiomyopathies | NA | CTD_human | Detail | |
<0.001 | Post MI | NA | BeFree | Detail | |
0.120 | Drug-Induced Liver Injury | NA | CTD_human | Detail | |
<0.001 | Intraepithelial Neoplasia | NA | BeFree | Detail | |
<0.001 | Cardiomyopathies | NA | BeFree | Detail | |
<0.001 | Pituitary Dwarfism Type 3 | NA | BeFree | Detail | |
0.006 | Growth failure | The results of the in-vitro study do not support the hypothesis that IGF-I/IGF-I... | BeFree | 25066218 | Detail |
0.006 | Growth failure | By contrast, IGF1 insensitivity results in pre- and postnatal growth failure ass... | BeFree | 25411237 | Detail |
<0.001 | Cerebral Ischemia | NA | BeFree | Detail | |
0.005 | ovarian neoplasm | NA | LHGDN | Detail | |
0.002 | Microsatellite Instability | NA | GAD | Detail | |
<0.001 | Metastatic Prostate Carcinoma | NA | BeFree | Detail | |
<0.001 | Ischemic stroke | NA | BeFree | Detail | |
0.003 | Acute coronary syndrome | NA | BeFree,LHGDN | Detail | |
<0.001 | Polyp of large intestine | Polymorphisms in the IGF1 and IGFBP3 genes may not be invariably determinant of ... | BeFree | 25385818 | Detail |
0.080 | Arthritis, Experimental | NA | RGD | Detail | |
<0.001 | Monoclonal Gammapathies | NA | BeFree | Detail | |
0.007 | Malignant neoplasm of ovary | NA | BeFree,GAD | Detail | |
<0.001 | endometrial adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of the head and neck | Our study indicated that there is no alteration of the levels of expression of I... | BeFree | 24802266 | Detail |
<0.001 | Myxoid cyst | Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retin... | BeFree | 25923430 | Detail |
<0.001 | Abnormal breathing | NA | BeFree | Detail | |
0.007 | sarcoma | NA | BeFree,LHGDN | Detail | |
<0.001 | major depressive disorder | IGF-I in major depression and antidepressant treatment response. | BeFree | 25836355 | Detail |
<0.001 | Mild cognitive disorder | Our findings support the association of a low IGF-1 level with reduced cognitive... | BeFree | 25467636 | Detail |
<0.001 | Exogenous obesity | NA | BeFree | Detail | |
<0.001 | Inflammatory disorder | NA | BeFree | Detail | |
<0.001 | Chronic inflammatory disorder | NA | BeFree | Detail | |
<0.001 | Cardiovascular morbidity | NA | BeFree | Detail | |
<0.001 | Adenoma of large intestine | NA | BeFree | Detail | |
<0.001 | Hereditary Malignant Neoplasm | NA | BeFree | Detail | |
<0.001 | Hereditary Nonpolyposis Colorectal Cancer | NA | BeFree | Detail | |
<0.001 | Malignant Smooth Muscle Neoplasm | NA | BeFree | Detail | |
<0.001 | Pericytic Neoplasm | NA | BeFree | Detail | |
<0.001 | Sporadic Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | differentiated thyroid gland carcinoma | NA | BeFree | Detail | |
<0.001 | Epithelioma | NA | BeFree | Detail | |
<0.001 | renal carcinoma | NA | BeFree | Detail | |
<0.001 | Generalized osteoarthritis | NA | BeFree | Detail | |
<0.001 | Systemic onset juvenile chronic arthritis | NA | BeFree | Detail | |
<0.001 | Cardiac fibrosis | Using a mouse model of ischemia-reperfusion, we demonstrate that intravenous del... | BeFree | 24604065 | Detail |
<0.001 | Axial myopia | NA | BeFree | Detail | |
0.189 | Mammary Neoplasms | Elevated GH/IGF-I promotes mammary tumors in high-fat, but not low-fat, fed mice... | BeFree,CTD_human,GAD,LHGDN | 25085903 | Detail |
<0.001 | histiocytoma | NA | BeFree | Detail | |
0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
<0.001 | Mammary Tumorigenesis | These results further support a role of GH/IGF-I in regulating mammary tumorigen... | BeFree | 25085903 | Detail |
<0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
<0.001 | Tumor Promotion | NA | BeFree | Detail | |
<0.001 | Xenograft Model | NA | BeFree | Detail | |
0.033 | colorectal cancer | These data suggested that inhibiting cytohesins or ARNO as cytoplasmic activator... | BeFree,GAD | 24618737 | Detail |
0.033 | colorectal cancer | Given the role of insulin resistance in colorectal cancer (CRC), we explored whe... | BeFree,GAD | 25557790 | Detail |
0.033 | colorectal cancer | We elucidated the potential signaling pathway, IFN-γ/IRF1/miR-29b/IGF1, and its ... | BeFree,GAD | 25592039 | Detail |
<0.001 | Non-Malignant Ascites Adverse Event | Advanced-stage ovarian carcinoma patients were first evaluated to show higher IG... | BeFree | 25592043 | Detail |
0.001 | Glioblastoma multiforme | NA | BeFree | Detail | |
0.002 | Cirrhosis | NA | BeFree | Detail | |
<0.001 | tumor vasculature | Important mechanisms we discuss include (1) improved DNA repair in normal, but n... | BeFree | 24436017 | Detail |
0.002 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
0.120 | Female Urogenital Diseases | NA | CTD_human | Detail | |
0.001 | Idiopathic Pulmonary Fibrosis | NA | BeFree | Detail | |
<0.001 | MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3 (disorder) | NA | BeFree | Detail | |
<0.001 | Bulbo-Spinal Atrophy, X-Linked | NA | BeFree | Detail | |
0.002 | Mammographic Density | NA | BeFree | Detail | |
<0.001 | Insulin-Like Growth Factor I, Resistance To | These results suggest that IGF-I increases in response to neuropathological chan... | BeFree | 24820016 | Detail |
<0.001 | Insulin-Like Growth Factor I, Resistance To | SRS children who carry such an epimutation have increased levels of IGF-I and IG... | BeFree | 25066218 | Detail |
<0.001 | Pygmy (disorder) | NA | BeFree | Detail | |
<0.001 | HYPERTRICHOSIS, CONGENITAL GENERALIZED | NA | BeFree | Detail | |
<0.001 | glucocorticoid deficiency 1 | NA | BeFree | Detail | |
<0.001 | acromesomelic dysplasia, Maroteaux type | NA | BeFree | Detail | |
0.003 | uterine corpus cancer | NA | BeFree | Detail | |
0.080 | Osteophyte | NA | BeFree,RGD | Detail | |
0.003 | coronary artery disease | NA | BeFree,GAD | Detail | |
<0.001 | plasma cell neoplasm | NA | BeFree | Detail | |
<0.001 | aromatase excess syndrome | NA | BeFree | Detail | |
<0.001 | Potassium depletion | NA | BeFree | Detail | |
<0.001 | Inflammatory acne | NA | BeFree | Detail | |
0.008 | liver carcinoma | In the present study, we report a novel insulin-like growth factor 1 (IGF1) path... | BeFree,GAD | 25420499 | Detail |
0.008 | liver carcinoma | The effects of IL6/IGFI on stemness expression in HCC were examined using OCT4/N... | BeFree,GAD | 25564572 | Detail |
0.008 | liver carcinoma | Unlike previous studies, our results did not confirm FUCA1, HGF, IGF1 or CgA as ... | BeFree,GAD | 25862856 | Detail |
<0.001 | Myeloblastic leukemia | NA | BeFree | Detail | |
<0.001 | Chronic kidney disease stage 5 | NA | BeFree | Detail | |
<0.001 | Pediatric Obesity | NA | BeFree | Detail | |
0.120 | Acute kidney injury | NA | CTD_human | Detail | |
0.002 | Weight Gain Adverse Event | NA | GAD | Detail | |
0.002 | Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | NA | GAD | Detail | |
<0.001 | Nasopharyngeal carcinoma | NA | BeFree | Detail | |
<0.001 | Obesity, Visceral | NA | BeFree | Detail | |
0.008 | Prostatic Hyperplasia | NA | GAD,LHGDN | Detail | |
<0.001 | Bisphosphonate-associated osteonecrosis | NA | BeFree | Detail | |
<0.001 | Ischemic Cerebrovascular Accident | NA | BeFree | Detail | |
<0.001 | Early Hepatocellular Carcinoma | NA | BeFree | Detail | |
<0.001 | Hydatidiform mole, recurrent, 1 | NA | BeFree | Detail | |
<0.001 | Progressive cGVHD | NA | BeFree | Detail | |
<0.001 | Triple Negative Breast Neoplasms | In the current study, the prognostic and predictive values of serum transforming... | BeFree | 25824321 | Detail |
<0.001 | Triple Negative Breast Neoplasms | VEGF-A, IGF-I and IGF-IR play an important role in the development and progressi... | BeFree | 26232605 | Detail |
<0.001 | Meckel syndrome type 1 | NA | BeFree | Detail | |
0.002 | Infection | NA | GAD | Detail | |
<0.001 | Dowling-Degos disease | In the DDD group, there were 10 cytokines and growth factors with significantly ... | BeFree | 25365709 | Detail |
0.003 | Isolated somatotropin deficiency | Endocrine evaluation revealed low IGF-1 levels and borderline growth hormone def... | BeFree | 24458596 | Detail |
0.003 | Isolated somatotropin deficiency | Patients with severe IGHD had a higher frequency of consanguinity, were shorter,... | BeFree | 25116472 | Detail |
<0.001 | Congenital Abnormality | NA | BeFree | Detail | |
0.122 | Spontaneous abortion | NA | CTD_human,GAD | Detail | |
0.003 | Acidosis | NA | LHGDN | Detail | |
<0.001 | Acne Vulgaris | The significant association between strong IGF-1, high BMI, and severe acne unde... | BeFree | 25803999 | Detail |
0.135 | acromegaly | The d3-GHR variant genotype did not have an effect on clinical features or comor... | BeFree,CTD_human,GAD,LHGDN | 24706164 | Detail |
0.135 | acromegaly | An uncontrolled hyperactive GH-IGF-1 axis may play a dominant role in the develo... | BeFree,CTD_human,GAD,LHGDN | 25329702 | Detail |
0.135 | acromegaly | Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acro... | BeFree,CTD_human,GAD,LHGDN | 25370837 | Detail |
0.135 | acromegaly | A retrospective observational study was conducted in patients with acromegaly to... | BeFree,CTD_human,GAD,LHGDN | 25385818 | Detail |
0.135 | acromegaly | Doses of the GH receptor (GHR) antagonist pegvisomant (PEGV) that normalize insu... | BeFree,CTD_human,GAD,LHGDN | 26243033 | Detail |
0.015 | adenocarcinoma | NA | BeFree,GAD,LHGDN | Detail | |
0.126 | adenoma | When compared to densely granulated tumors, sparsely granulated adenomas were as... | BeFree,CTD_human,GAD | 25238988 | Detail |
<0.001 | Osteoporosis, Age-Related | NA | BeFree | Detail | |
<0.001 | AIDS Dementia Complex | NA | BeFree | Detail | |
0.130 | Alzheimer's disease | Hence, IGF2 and, to a lesser extent, IGF1 may be effective treatments for Alzhei... | BeFree,CTD_human,GAD,LHGDN | 25100745 | Detail |
0.002 | amyotrophic lateral sclerosis | NA | BeFree | Detail | |
0.003 | Anemia, Sickle Cell | NA | BeFree,LHGDN | Detail | |
<0.001 | cutaneous fibrous histiocytoma | NA | BeFree | Detail | |
<0.001 | Anophthalmos | NA | BeFree | Detail | |
<0.001 | anorexia nervosa | NA | BeFree | Detail | |
0.005 | Anoxia | NA | LHGDN | Detail | |
<0.001 | aortic valve stenosis | NA | BeFree | Detail | |
0.004 | arteriosclerosis | NA | BeFree | Detail | |
0.003 | Arteriovenous fistula | NA | LHGDN | Detail | |
0.004 | rheumatoid arthritis | These results indicate that aberrant IGF-I and IGFBP-3 production plays a role i... | BeFree,LHGDN | 25352179 | Detail |
0.001 | Astrocytoma | NA | BeFree | Detail | |
<0.001 | Ataxia | NA | BeFree | Detail | |
<0.001 | ataxia telangiectasia | NA | BeFree | Detail | |
0.011 | atherosclerosis | NA | BeFree,GAD,LHGDN | Detail | |
0.122 | autistic disorder | NA | CTD_human,GAD | Detail | |
0.003 | Barrett esophagus | NA | BeFree,GAD | Detail | |
0.003 | beta thalassemia | NA | LHGDN | Detail | |
<0.001 | biliary atresia | NA | BeFree | Detail | |
<0.001 | bipolar disorder | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of urinary bladder | NA | BeFree,GAD | Detail | |
0.121 | Bladder Neoplasm | NA | BeFree,CTD_human | Detail | |
<0.001 | Blast Phase | NA | BeFree | Detail | |
0.122 | Metabolic Bone Disorder | NA | CTD_human,GAD | Detail | |
0.002 | Brain Neoplasms | NA | GAD | Detail | |
0.099 | Malignant neoplasm of breast | Growth hormone (GH) and/or insulin-like growth factor I (IGF-I) are thought to p... | BeFree,GAD | 25085903 | Detail |
0.099 | Malignant neoplasm of breast | IGF-1 is a point of convergence for major signaling pathways implicated in breas... | BeFree,GAD | 25743390 | Detail |
0.099 | Malignant neoplasm of breast | Induction of anterior gradient 2 (AGR2) plays a key role in insulin-like growth ... | BeFree,GAD | 25956506 | Detail |
0.003 | breast cyst | NA | LHGDN | Detail | |
0.002 | Breast Diseases | NA | GAD | Detail | |
0.003 | bronchopulmonary dysplasia | NA | BeFree,GAD | Detail | |
0.004 | Cachexia | NA | BeFree,LHGDN | Detail | |
0.003 | Carcinoid Tumor | NA | BeFree,LHGDN | Detail | |
0.006 | Malignant tumor of colon | NA | BeFree,GAD | Detail | |
0.003 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
<0.001 | Rectal Carcinoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of skin | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
0.004 | Non-small cell lung carcinoma | NA | BeFree | Detail | |
0.006 | renal cell carcinoma | NA | BeFree,LHGDN | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The association between these polymorphisms, tissue and blood serum levels of IGF‑1, and cervical ca... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These data suggested that inhibiting cytohesins or ARNO as cytoplasmic activators of EGFR and IGF-I ... | DisGeNET | Detail |
Given the role of insulin resistance in colorectal cancer (CRC), we explored whether genetic variant... | DisGeNET | Detail |
We elucidated the potential signaling pathway, IFN-γ/IRF1/miR-29b/IGF1, and its implication for CRC ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These results suggest that IGF-I increases in response to neuropathological changes in dementia and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In our study, elevated IGF-I levels were significantly associated with depression and impaired treat... | DisGeNET | Detail |
In our study, elevated IGF-I levels were significantly associated with depression and impaired treat... | DisGeNET | Detail |
These findings suggest that IGF-1 is an important paracrine factor that mediates the therapeutic eff... | DisGeNET | Detail |
These findings suggest that IGF-1 is an important paracrine factor that mediates the therapeutic eff... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The Uyghur population and genetic susceptibility to type 2 diabetes: potential role for variants in ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The GH and IGF-1 characteristics of children with short stature were not different between children ... | DisGeNET | Detail |
Given the relative common occurrence of defects of the GH/IGF-I axis in children with short stature ... | DisGeNET | Detail |
The current study evaluates the relative contribution of these two factors controlling individual GH... | DisGeNET | Detail |
Patients with severe IGHD had a higher frequency of consanguinity, were shorter, had lower levels of... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The results of the in-vitro study do not support the hypothesis that IGF-I/IGF-II resistance is a ma... | DisGeNET | Detail |
By contrast, IGF1 insensitivity results in pre- and postnatal growth failure associated with relativ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Examples of the latter include mGluR5 antagonists in FXS, mTOR inhibitors in TSC and insulin-like gr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In an effort to determine whether hNPs could be used a candidate cells for targeted delivery of neur... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To evaluate the expression of different insulin-like growth factor (IGF)-1 mRNA isoforms and IGF-1 r... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochon... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Using a mouse model of ischemia-reperfusion, we demonstrate that intravenous delivery of Hoechst-IGF... | DisGeNET | Detail |
In our study, BMSCs were modified with insulin-like growth factor-1 (IGF-1) gene, loaded into a fibr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A subset of bone marrow stromal cells regulate ATP-binding cassette gene expression via insulin-like... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, the involvement of IGF-I in inducing multidrug resistance in a myeloid leukemia cell line, gro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Together, IGF-1/Akt/FoxO1 regulatory machinery appears to be a previously unappreciated signaling ax... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Excessive secretion of the growth hormone (GH) leads to hepatic secretion of insulin-like growth fac... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To identify and characterize IGF1R gene variations in a cohort of 28 Argentinean children suspected ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
RGZ was able to concentration‑dependently inhibit the expression of HIF1α and IGF1 mRNA in RPMI-8226... | DisGeNET | Detail |
Furthermore, exposure of AZD8055-treated cells to IGF1 induced p-Akt S(473) and rescued multiple mye... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Spinal muscular atrophy mice administered AAV1-IGF-1 on postnatal day 1 exhibited a lower extent of ... | DisGeNET | Detail |
These data indicate that systemically delivered AAV1-IGF-1 can correct several of the biochemical an... | DisGeNET | Detail |
Recent evidence of IGF-1 axis alteration in spinal muscular atrophy (SMA), a very severe neurodegene... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Using a mouse model of ischemia-reperfusion, we demonstrate that intravenous delivery of Hoechst-IGF... | DisGeNET | Detail |
Localized delivery of mechano-growth factor E-domain peptide via polymeric microstructures improves ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
IFN-γ-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by... | DisGeNET | Detail |
Although many of the relevant molecular pathways and intracellular cascades remain to be elucidated,... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
An increased expression of LEP and IGF1 was detected in the subcutaneous fat of the obese group comp... | DisGeNET | Detail |
Relationship between serum IGF-1 and skeletal muscle IGF-1 mRNA expression to phosphocreatine recove... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Three specific genes in the pain group overlap with sleep quality, including insulin-like growth fac... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Furthermore, precocious ethynylestradiol (EE) exposure induced lasting effects on growth, through pi... | DisGeNET | Detail |
Analysis of the GH/IGF1 pathway was done evaluating the expression of several hypothalamic-pituitary... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Regarding the IGFBP3 polymorphism, the absence of an A allele at the -202 position was associated wi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Examples of the latter include mGluR5 antagonists in FXS, mTOR inhibitors in TSC and insulin-like gr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
IGF-1 and ADMA levels are inversely correlated in nondiabetic ankylosing spondylitis patients underg... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
IGF-I in major depression and antidepressant treatment response. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The absence of Esr2 resulted in increased apoptosis, decreased B-cell lymphoma 2 (BCL2), and IGF-1 r... | DisGeNET | Detail |
Recent evidence of IGF-1 axis alteration in spinal muscular atrophy (SMA), a very severe neurodegene... | DisGeNET | Detail |
NA | DisGeNET | Detail |
GO terms relevant to translation and metabolic process and their related genes CREB1, ribosomal prot... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Sur... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results suggest that TM4SF4 overexpression in lung carcinoma cells results in resistance to radi... | DisGeNET | Detail |
Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
IGF-I sensitivity in Silver-Russell syndrome with IGF2/H19 hypomethylation. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
An uncontrolled hyperactive GH-IGF-1 axis may play a dominant role in the development of PTC rather ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Endocrine evaluation revealed low IGF-1 levels and borderline growth hormone deficiency. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In somatotropinomas, sst5TMD4 mRNA and protein levels correlated positively, and its expression was ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Analysis of cytosine-adenine repeats in P1 promoter region of IGF-1 gene in peripheral blood cells a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The association between these polymorphisms, tissue and blood serum levels of IGF‑1, and cervical ca... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study. | DisGeNET | Detail |
A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inhibition in prostate ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Analysis of the association of COL2A1 and IGF-1 with mandibular prognathism in a Chinese population. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Metformin down-regulates endometrial carcinoma cell secretion of IGF-1 and expression of IGF-1R. | DisGeNET | Detail |
These results suggest that IGF-I increases in response to neuropathological changes in dementia and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
As loss of protein homeostasis is a feature of many sporadic and inherited forms of neurodegenerativ... | DisGeNET | Detail |
This aspect should be considered when designing IGF-1-based treatments for neurodegenerative disease... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
By chromatin immunoprecipitation, we analyzed EWS-FLI1 binding to the promoters of several target ge... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To better understand the role GH/IGF-I plays in tumor formation, this study used unique mouse models... | DisGeNET | Detail |
Together, IGF-1/Akt/FoxO1 regulatory machinery appears to be a previously unappreciated signaling ax... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study. | DisGeNET | Detail |
A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inhibition in prostate ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Growth hormone (GH) and/or insulin-like growth factor I (IGF-I) are thought to promote breast cancer... | DisGeNET | Detail |
IGF-1 is a point of convergence for major signaling pathways implicated in breast cancer growth. | DisGeNET | Detail |
Induction of anterior gradient 2 (AGR2) plays a key role in insulin-like growth factor-1 (IGF-1)-ind... | DisGeNET | Detail |
JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IG... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Together, IGF-1/Akt/FoxO1 regulatory machinery appears to be a previously unappreciated signaling ax... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The significant association between strong IGF-1, high BMI, and severe acne underscores the value of... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The results of the in-vitro study do not support the hypothesis that IGF-I/IGF-II resistance is a ma... | DisGeNET | Detail |
By contrast, IGF1 insensitivity results in pre- and postnatal growth failure associated with relativ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Polymorphisms in the IGF1 and IGFBP3 genes may not be invariably determinant of treatment outcome in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our study indicated that there is no alteration of the levels of expression of IGF2, E2F3 and IGF1 i... | DisGeNET | Detail |
Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Sur... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
IGF-I in major depression and antidepressant treatment response. | DisGeNET | Detail |
Our findings support the association of a low IGF-1 level with reduced cognitive function and gait s... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Using a mouse model of ischemia-reperfusion, we demonstrate that intravenous delivery of Hoechst-IGF... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Elevated GH/IGF-I promotes mammary tumors in high-fat, but not low-fat, fed mice. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These results further support a role of GH/IGF-I in regulating mammary tumorigenesis but suggest the... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These data suggested that inhibiting cytohesins or ARNO as cytoplasmic activators of EGFR and IGF-I ... | DisGeNET | Detail |
Given the role of insulin resistance in colorectal cancer (CRC), we explored whether genetic variant... | DisGeNET | Detail |
We elucidated the potential signaling pathway, IFN-γ/IRF1/miR-29b/IGF1, and its implication for CRC ... | DisGeNET | Detail |
Advanced-stage ovarian carcinoma patients were first evaluated to show higher IGF-1 and IGF-2 concen... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Important mechanisms we discuss include (1) improved DNA repair in normal, but not tumor cells; (2) ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These results suggest that IGF-I increases in response to neuropathological changes in dementia and ... | DisGeNET | Detail |
SRS children who carry such an epimutation have increased levels of IGF-I and IGFBP-3 in relation to... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In the present study, we report a novel insulin-like growth factor 1 (IGF1) pathway that mediates de... | DisGeNET | Detail |
The effects of IL6/IGFI on stemness expression in HCC were examined using OCT4/NANOG promoter lucife... | DisGeNET | Detail |
Unlike previous studies, our results did not confirm FUCA1, HGF, IGF1 or CgA as potential markers fo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In the current study, the prognostic and predictive values of serum transforming growth factor-β1 (T... | DisGeNET | Detail |
VEGF-A, IGF-I and IGF-IR play an important role in the development and progression of TNBC compared ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In the DDD group, there were 10 cytokines and growth factors with significantly increased expression... | DisGeNET | Detail |
Endocrine evaluation revealed low IGF-1 levels and borderline growth hormone deficiency. | DisGeNET | Detail |
Patients with severe IGHD had a higher frequency of consanguinity, were shorter, had lower levels of... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The significant association between strong IGF-1, high BMI, and severe acne underscores the value of... | DisGeNET | Detail |
The d3-GHR variant genotype did not have an effect on clinical features or comorbidity in acromegali... | DisGeNET | Detail |
An uncontrolled hyperactive GH-IGF-1 axis may play a dominant role in the development of PTC rather ... | DisGeNET | Detail |
Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acromegaly. | DisGeNET | Detail |
A retrospective observational study was conducted in patients with acromegaly to analyze IGF1 and IG... | DisGeNET | Detail |
Doses of the GH receptor (GHR) antagonist pegvisomant (PEGV) that normalize insulin-like growth fact... | DisGeNET | Detail |
NA | DisGeNET | Detail |
When compared to densely granulated tumors, sparsely granulated adenomas were associated with a youn... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Hence, IGF2 and, to a lesser extent, IGF1 may be effective treatments for Alzheimer's disease. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These results indicate that aberrant IGF-I and IGFBP-3 production plays a role in abnormal osteoclas... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Growth hormone (GH) and/or insulin-like growth factor I (IGF-I) are thought to promote breast cancer... | DisGeNET | Detail |
IGF-1 is a point of convergence for major signaling pathways implicated in breast cancer growth. | DisGeNET | Detail |
Induction of anterior gradient 2 (AGR2) plays a key role in insulin-like growth factor-1 (IGF-1)-ind... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386626619 dbSNP
- Genome
- hg38
- Position
- chr12:102,395,874-102,481,744
- Variant Type
- snv
Genome browser